Last updated: 2026-09-18 05:32:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $270.26, with a market capitalisation of $643.92B and a P/E ratio of 30.62. Over the past 52 weeks, its price has ranged from $173.33 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$643.92B | |
$268.00 | |
$281.07 | |
$46.25 | |
$267.28 | |
4.08M | |
7.56M | |
30.62 | |
$281.07 | |
$173.33 | |
1.96% | |
-- |
Johnson & Johnson (JNJ) last closed at $267.28 as of 2026-09-17 23:51:37, unchanged from the previous close of $267.28.
During the latest regular trading session, JNJ traded between $46.25 and $281.07, with a volume of 4.08M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $269.12 to $270.26, representing a gain of 0.43% ($1.14).
The stock traded between $260.68 and $271.99 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 5.54 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 90.0%
JNJ is currently trading at $270.26, placing it 90.0% of the way from its 52-week low of $173.33 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.